(Q34227082)

31 July 2017

1 reference

title

Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy (English)

1 reference

systemic lupus erythematosus

31 July 2017

1 reference

1 reference

1

M Petri

1 reference

31 July 2017

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

10

1 reference

31 July 2017

222-226

1 reference

31 July 2017

3

1 reference

Disassociation of sex hormone levels and cytokine production in SLE patients

31 July 2017

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Oral contraceptives and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

The effect of sex steroids on the skeleton in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Stroke in users of low-dose oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Hormonal treatment of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Serum estrogen levels, cognitive performance, and risk of cognitive decline in older community women

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Estrogen use and verbal memory in healthy postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Cognitive decline in women in relation to non-protein-bound oestradiol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Estrogen-progestin replacement therapy and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301676707393

10.1191/096120301676707393

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11315357